{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:52:56Z","timestamp":1791499976320,"version":"4.3.4"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014824","name":"Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ejmech.2025.117791","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T12:03:16Z","timestamp":1748001796000},"page":"117791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Insights into PTP1B inhibitors as antidiabetic agents: Current research and future perspectives"],"prefix":"10.1016","volume":"295","author":[{"given":"Abu Sahban","family":"Haider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Ambatwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3993-8114","authenticated-orcid":false,"given":"Gopal L.","family":"Khatik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6865","key":"10.1016\/j.ejmech.2025.117791_bib1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/414782a","article-title":"Global and societal implications of the diabetes epidemic","volume":"414","author":"Zimmet","year":"2001","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ejmech.2025.117791_bib2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41574-022-00690-7","article-title":"The burden and risks of emerging complications of diabetes mellitus","volume":"18","author":"Tomic","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"issue":"10467","key":"10.1016\/j.ejmech.2025.117791_bib3","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(24)02422-X","article-title":"Rising diabetes, lagging treatment, and the need for better systems","volume":"404","author":"Guariguata","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.117791_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2337\/diaclin.29.3.116","article-title":"Microvascular and macrovascular complications of diabetes","volume":"29","author":"Fowler","year":"2011","journal-title":"Clin. Diabetes"},{"issue":"4","key":"10.1016\/j.ejmech.2025.117791_bib5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nrendo.2011.183","article-title":"The worldwide epidemiology of type 2 diabetes mellitus\u2014present and future perspectives","volume":"8","author":"Chen","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejmech.2025.117791_bib6","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.2337\/dc22-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in Diabetes\u20142022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"issue":"9786","key":"10.1016\/j.ejmech.2025.117791_bib7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0140-6736(11)60207-9","article-title":"Management of type 2 diabetes: new and future developments in treatment","volume":"378","author":"Tahrani","year":"2011","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ejmech.2025.117791_bib8","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.amjmed.2012.05.008","article-title":"Management of type 2 diabetes: new and future developments in treatment","volume":"125","author":"Liao","year":"2012","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117791_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1517\/13543784.2012.657797","article-title":"The therapeutic potential of GPR119 agonists for type 2 diabetes","volume":"21","author":"Ohishi","year":"2012","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"6","key":"10.1016\/j.ejmech.2025.117791_bib10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.cell.2004.05.018","article-title":"Protein tyrosine phosphatases in the human genome","volume":"117","author":"Alonso","year":"2004","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.ejmech.2025.117791_bib11","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0968-0004(00)01712-6","article-title":"The regulation of protein function by multisite phosphorylation - 25 year update","volume":"25","author":"Cohen","year":"2000","journal-title":"Trends Biochem. Sci."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117791_bib12","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1083\/jcb.130.4.977","article-title":"Receptor protein tyrosine phosphatase PTPmu associates with cadherins and catenins in vivo","volume":"130","author":"Brady-Kalnay","year":"1995","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117791_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81357-4","article-title":"From form to function: signaling by protein tyrosine phosphatases","volume":"87","author":"Tonks","year":"1996","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117791_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0092-8674(95)90405-0","article-title":"Protein kinases and phosphatases: the yin and Yang of protein phosphorylation and signaling","volume":"80","author":"Hunter","year":"1995","journal-title":"Cell"},{"issue":"9\u201310","key":"10.1016\/j.ejmech.2025.117791_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.drudis.2007.03.011","article-title":"PTP1B as a drug target: recent developments in PTP1B inhibitor discovery","volume":"12","author":"Zhang","year":"2007","journal-title":"Drug Discov. Today"},{"issue":"33","key":"10.1016\/j.ejmech.2025.117791_bib16","doi-asserted-by":"crossref","first-page":"19810","DOI":"10.1074\/jbc.271.33.19810","article-title":"Protein-tyrosine phosphatase 1B is a negative regulator of Insulin- and insulin-like growth Factor-I-Stimulated signaling","volume":"271","author":"Kenner","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"1\/2","key":"10.1016\/j.ejmech.2025.117791_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/A:1006868409841","article-title":"Protein-tyrosine Phosphatase-1B acts as a negative regulator of insulin signal transduction","volume":"182","author":"Byon","year":"1998","journal-title":"Mol. Cell. Biochem."},{"issue":"15","key":"10.1016\/j.ejmech.2025.117791_bib18","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1128\/MCB.20.15.5479-5489.2000","article-title":"Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-Deficient mice","volume":"20","author":"Klaman","year":"2000","journal-title":"Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117791_bib19","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1172\/JCI117068","article-title":"Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance","volume":"93","author":"Kusari","year":"1994","journal-title":"J. Clin. Investig."},{"issue":"8825","key":"10.1016\/j.ejmech.2025.117791_bib20","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0140-6736(92)92814-V","article-title":"Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-Year Follow-up study","volume":"340","author":"Martin","year":"1992","journal-title":"Lancet"},{"issue":"5407","key":"10.1016\/j.ejmech.2025.117791_bib21","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1126\/science.283.5407.1544","article-title":"Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine Phosphatase-1B gene","volume":"283","author":"Elchebly","year":"1999","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ejmech.2025.117791_bib22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1534-5807(02)00148-X","article-title":"PTP1B regulates leptin signal transduction in vivo","volume":"2","author":"Zabolotny","year":"2002","journal-title":"Dev. Cell"},{"issue":"4","key":"10.1016\/j.ejmech.2025.117791_bib23","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1534-5807(02)00149-1","article-title":"Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B","volume":"2","author":"Cheng","year":"2002","journal-title":"Dev. Cell"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117791_bib24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1517\/13543784.12.2.223","article-title":"PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity","volume":"12","author":"Zhang","year":"2003","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"14","key":"10.1016\/j.ejmech.2025.117791_bib25","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1073\/pnas.86.14.5257","article-title":"CDNA isolated from a human T-Cell library encodes a member of the protein-tyrosine-phosphatase family","volume":"86","author":"Cool","year":"1989","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117791_bib26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1006\/smim.2000.0220","article-title":"The T-Cell protein tyrosine phosphatase","volume":"12","author":"Ibarra-S\u00e1nchez","year":"2000","journal-title":"Semin. Immunol."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117791_bib27","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.4155\/fmc.10.241","article-title":"Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development","volume":"2","author":"Barr","year":"2010","journal-title":"Future Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117791_bib28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11154-013-9282-4","article-title":"Role of protein tyrosine phosphatases in the modulation of insulin signaling and their implication in the pathogenesis of obesity-linked insulin resistance","volume":"15","author":"Xu","year":"2014","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117791_bib29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0092-8674(92)90190-N","article-title":"The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-Terminal sequence","volume":"68","author":"Frangioni","year":"1992","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117791_bib30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1021\/acs.accounts.6b00537","article-title":"Drugging the undruggable: therapeutic potential of targeting protein tyrosine phosphatases","volume":"50","author":"Zhang","year":"2017","journal-title":"Acc. Chem. Res."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117791_bib31","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2170369","article-title":"The importance of including the C-Terminal domain of PTP1B 1-400 to identify potential antidiabetic inhibitors","volume":"38","author":"Coronell-Tovar","year":"2023","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117791_bib32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1021\/ar020122r","article-title":"Chemical and mechanistic approaches to the study of protein tyrosine phosphatases","volume":"36","author":"Zhang","year":"2003","journal-title":"Acc. Chem. Res."},{"issue":"5152","key":"10.1016\/j.ejmech.2025.117791_bib33","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1126\/science.8128219","article-title":"Crystal structure of human protein tyrosine phosphatase 1B","volume":"263","author":"Barford","year":"1994","journal-title":"Science"},{"issue":"5266","key":"10.1016\/j.ejmech.2025.117791_bib34","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.272.5266.1328","article-title":"Crystal structure of the dual specificity protein phosphatase VHR","volume":"272","author":"Yuvaniyama","year":"1996","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ejmech.2025.117791_bib35","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1073\/pnas.91.5.1624","article-title":"Dissecting the catalytic mechanism of protein-tyrosinephosphatases","volume":"91","author":"Zhang","year":"1994","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5218","key":"10.1016\/j.ejmech.2025.117791_bib36","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1126\/science.7540771","article-title":"Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B","volume":"268","author":"Jia","year":"1995","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.ejmech.2025.117791_bib37","doi-asserted-by":"crossref","first-page":"7117","DOI":"10.1128\/MCB.21.21.7117-7136.2001","article-title":"Structural and evolutionary relationships among protein tyrosine phosphatase domains","volume":"21","author":"Andersen","year":"2001","journal-title":"Mol. Cell Biol."},{"issue":"49","key":"10.1016\/j.ejmech.2025.117791_bib38","doi-asserted-by":"crossref","first-page":"38013","DOI":"10.1074\/jbc.M607913200","article-title":"Structural insights into the design of nonpeptidic Isothiazolidinone-Containing inhibitors of protein-tyrosine phosphatase 1B","volume":"281","author":"Ala","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.ejmech.2025.117791_bib39","doi-asserted-by":"crossref","first-page":"7079","DOI":"10.1016\/j.bmc.2015.09.024","article-title":"Novel, potent, selective and cellular active ABC type PTP1B inhibitors containing (Methanesulfonyl-Phenyl-Amino)-Acetic acid Methyl Ester Phosphotyrosine mimetic","volume":"23","author":"Liu","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117791_bib40","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ejmech.2017.12.064","article-title":"Discovery of novel high potent and cellular active ADC type PTP1B inhibitors with selectivity over TC-PTP via modification interacting with C site","volume":"144","author":"Du","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"21","key":"10.1016\/j.ejmech.2025.117791_bib41","doi-asserted-by":"crossref","first-page":"15874","DOI":"10.1074\/jbc.M109.066951","article-title":"Insights into the reaction of protein-tyrosine phosphatase 1B: crystal structures for transition state analogs of both catalytic steps","volume":"285","author":"Brandao","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117791_bib42","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1021\/acs.chemrev.7b00105","article-title":"Regulatory mechanisms and novel therapeutic targeting strategies for protein tyrosine phosphatases","volume":"118","author":"Yu","year":"2018","journal-title":"Chem. Rev."},{"issue":"26","key":"10.1016\/j.ejmech.2025.117791_bib43","doi-asserted-by":"crossref","first-page":"17026","DOI":"10.1016\/S0021-9258(19)47335-3","article-title":"Evidence for protein-tyrosine-phosphatase catalysis proceeding via a cysteine-phosphate intermediate","volume":"266","author":"Guan","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"18","key":"10.1016\/j.ejmech.2025.117791_bib44","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1021\/ja00044a052","article-title":"Isolation and structural elucidation of a novel phosphocysteine intermediate in the LAR protein tyrosine phosphatase Enzymic Pathway","volume":"114","author":"Cho","year":"1992","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117791_bib45","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1073\/pnas.93.6.2493","article-title":"Visualization of intermediate and transition-state structures in protein-tyrosine phosphatase catalysis","volume":"93","author":"Denu","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"17","key":"10.1016\/j.ejmech.2025.117791_bib46","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1021\/bi952885a","article-title":"Probing the function of Asp128 in the low molecular weight protein-tyrosine phosphatase-catalyzed reaction. A pre-steady-state and steady-state kinetic investigation","volume":"35","author":"Wu","year":"1996","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/j.ejmech.2025.117791_bib47","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1074\/jbc.273.10.5484","article-title":"Altering the nucleophile specificity of a protein-tyrosine phosphatase-catalyzed reaction","volume":"273","author":"Zhao","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"32","key":"10.1016\/j.ejmech.2025.117791_bib48","doi-asserted-by":"crossref","first-page":"12634","DOI":"10.1021\/jacs.9b04470","article-title":"Uncovering the molecular interactions in the catalytic loop that modulate the conformational dynamics in protein tyrosine phosphatase 1B","volume":"141","author":"Cui","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"13","key":"10.1016\/j.ejmech.2025.117791_bib49","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1021\/acs.jcim.3c00286","article-title":"A conserved local structural motif controls the kinetics of PTP1B catalysis","volume":"63","author":"Yeh","year":"2023","journal-title":"J. Chem. Inf. Model."},{"issue":"45","key":"10.1016\/j.ejmech.2025.117791_bib50","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.1021\/acs.biochem.8b00656","article-title":"Evolutionarily conserved allosteric communication in protein tyrosine phosphatases","volume":"57","author":"Hjortness","year":"2018","journal-title":"Biochemistry"},{"issue":"39","key":"10.1016\/j.ejmech.2025.117791_bib51","doi-asserted-by":"crossref","first-page":"8305","DOI":"10.1021\/acs.jpcb.3c03791","article-title":"Biophysical rationale for the selective inhibition of PTP1B over TCPTP by nonpolar terpenoids","volume":"127","author":"Friedman","year":"2023","journal-title":"J. Phys. Chem. B"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117791_bib52","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1038\/s41467-018-06814-w","article-title":"Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2","volume":"9","author":"P\u00e1dua","year":"2018","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.ejmech.2025.117791_bib53","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1021\/jacsau.4c00078","article-title":"SHP-1 variants broaden the understanding of PH-Dependent activities in protein tyrosine phosphatases","volume":"4","author":"Shen","year":"2024","journal-title":"JACS Au"},{"issue":"5","key":"10.1016\/j.ejmech.2025.117791_bib54","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1021\/jm950621g","article-title":"4\u2018-O-[2-(2-Fluoromalonyl)]-l-Tyrosine: a phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptides","volume":"39","author":"Burke","year":"1996","journal-title":"J. Med. Chem."},{"issue":"34","key":"10.1016\/j.ejmech.2025.117791_bib55","doi-asserted-by":"crossref","first-page":"9981","DOI":"10.1016\/S0040-4020(98)00590-0","article-title":"Enantioselective synthesis of Nonphosphorus-Containing phosphotyrosyl mimetics and their use in the preparation of tyrosine phosphatase inhibitory peptides","volume":"54","author":"Burke","year":"1998","journal-title":"Tetrahedron"},{"issue":"9","key":"10.1016\/j.ejmech.2025.117791_bib56","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0960-894X(00)00124-4","article-title":"Examination of novel non-phosphorus-containing phosphotyrosyl mimetics against protein-tyrosine Phosphatase-1B and demonstration of differential affinities toward Grb2 SH2 domains","volume":"10","author":"Gao","year":"2000","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"18","key":"10.1016\/j.ejmech.2025.117791_bib57","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1021\/jm010020r","article-title":"Utilization of a peptide lead for the discovery of a novel PTP1B-Binding motif","volume":"44","author":"Gao","year":"2001","journal-title":"J. Med. Chem."},{"issue":"25","key":"10.1016\/j.ejmech.2025.117791_bib58","doi-asserted-by":"crossref","first-page":"13420","DOI":"10.1073\/pnas.94.25.13420","article-title":"Identification of a second Aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design","volume":"94","author":"Puius","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"20","key":"10.1016\/j.ejmech.2025.117791_bib59","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1021\/jm034122o","article-title":"Fragment screening and assembly: a highly efficient approach to a selective and cell active protein tyrosine phosphatase 1B inhibitor","volume":"46","author":"Liu","year":"2003","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117791_bib60","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1021\/ci800104s","article-title":"Studies of the mechanism of selectivity of protein tyrosine phosphatase 1B (PTP1B) bidentate inhibitors using molecular dynamics simulations and free energy calculations","volume":"48","author":"Fang","year":"2008","journal-title":"J. Chem. Inf. Model."},{"issue":"9","key":"10.1016\/j.ejmech.2025.117791_bib61","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1021\/acsmedchemlett.5b00171","article-title":"Identification of bidentate salicylic acid inhibitors of PTP1B","volume":"6","author":"Haftchenary","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117791_bib62","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1021\/acs.jcim.8b00040","article-title":"Virtual screening of novel and selective inhibitors of protein tyrosine phosphatase 1B over T-Cell protein tyrosine phosphatase using a bidentate inhibition strategy","volume":"58","author":"Chen","year":"2018","journal-title":"J. Chem. Inf. Model."},{"issue":"8","key":"10.1016\/j.ejmech.2025.117791_bib63","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nsmb803","article-title":"Allosteric inhibition of protein tyrosine phosphatase 1B","volume":"11","author":"Wiesmann","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"7","key":"10.1016\/j.ejmech.2025.117791_bib64","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nchembio.1528","article-title":"Targeting the disordered C terminus of PTP1B with an allosteric inhibitor","volume":"10","author":"Krishnan","year":"2014","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117791_bib65","doi-asserted-by":"crossref","first-page":"144a","DOI":"10.1016\/j.bpj.2021.11.1995","article-title":"Revealing the allosteric pathways of the protein-tyrosine phosphatase 1B: a combined mutagenesis-computational study","volume":"121","author":"Liu","year":"2022","journal-title":"Biophys. J."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117791_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/pro.5024","article-title":"Native dynamics and allosteric responses in <scp>PTP1B<\/Scp> probed by high\u2010resolution <scp>HDX\u2010MS<\/Scp&gt","volume":"33","author":"Woods","year":"2024","journal-title":"Protein Sci."},{"issue":"9","key":"10.1016\/j.ejmech.2025.117791_bib67","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1021\/acs.jcim.3c00236","article-title":"Discovery and validation of the binding poses of allosteric fragment hits to protein tyrosine phosphatase 1b: from molecular dynamics simulations to X-Ray crystallography","volume":"63","author":"Greisman","year":"2023","journal-title":"J. Chem. Inf. Model."},{"issue":"8","key":"10.1016\/j.ejmech.2025.117791_bib68","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1021\/ci200581g","article-title":"Molecular dynamics approach to probe the allosteric inhibition of PTP1B by chlorogenic and cichoric acid","volume":"52","author":"Baskaran","year":"2012","journal-title":"J. Chem. Inf. Model."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117791_bib69","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1021\/acs.biochem.0c00841","article-title":"Optogenetic analysis of allosteric control in protein tyrosine phosphatases","volume":"60","author":"Hongdusit","year":"2021","journal-title":"Biochemistry"},{"issue":"42","key":"10.1016\/j.ejmech.2025.117791_bib70","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.1021\/acs.jpcb.2c05423","article-title":"Allosteric inhibition of PTP1B by a nonpolar terpenoid","volume":"126","author":"Friedman","year":"2022","journal-title":"J. Phys. Chem. B"},{"issue":"9","key":"10.1016\/j.ejmech.2025.117791_bib71","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1021\/acs.jcim.1c00357","article-title":"Integrated approach to identify selective PTP1B inhibitors targeting the allosteric site","volume":"61","author":"Yang","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"7","key":"10.1016\/j.ejmech.2025.117791_bib72","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1021\/acsmedchemlett.1c00662","article-title":"Contemporary computational applications and tools in drug discovery","volume":"13","author":"Cox","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117791_bib73","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/cbdd.12283","article-title":"The discovery of a novel and selective inhibitor of PTP1B over TCPTP: 3D QSAR pharmacophore modeling, virtual screening, synthesis, and biological evaluation","volume":"83","author":"Ma","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"issue":"18","key":"10.1016\/j.ejmech.2025.117791_bib74","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/cmdc.201800267","article-title":"Combined ligand\u2010 and receptor\u2010based virtual screening methodology to identify structurally diverse protein tyrosine phosphatase 1B inhibitors","volume":"13","author":"Gimeno","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117791_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2023.108585","article-title":"Exploring the mechanism of the PTP1B inhibitors by molecular dynamics and experimental study","volume":"125","author":"Zhao","year":"2023","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ejmech.2025.117791_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113990","article-title":"Status of research on natural protein tyrosine phosphatase 1B inhibitors as potential antidiabetic agents: update","volume":"157","author":"Liu","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117791_bib77","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/aps.2012.90","article-title":"Natural products possessing protein tyrosine phosphatase 1B (PTP1B) inhibitory activity found in the last decades","volume":"33","author":"Jiang","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117791_bib78","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1021\/acs.jnatprod.9b00777","article-title":"Stilbenes with potent protein tyrosine Phosphatase-1B inhibitory activity from the roots of Polygonum multiflorum","volume":"83","author":"Nguyen","year":"2020","journal-title":"J. Nat. Prod."},{"issue":"12","key":"10.1016\/j.ejmech.2025.117791_bib79","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1021\/acs.jnatprod.2c00879","article-title":"Selective inhibition of PTP1B by new anthraquinone glycosides from Knoxia Valerianoides","volume":"85","author":"Zhang","year":"2022","journal-title":"J. Nat. Prod."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117791_bib80","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s11418-020-01448-z","article-title":"PTP1B and \u03b1-Glucosidase inhibitors from Selaginella Rolandi-Principis and their glucose uptake stimulation","volume":"75","author":"Nguyen","year":"2021","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.ejmech.2025.117791_bib81","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ejmech.2014.09.036","article-title":"Synthesis of oleanolic acid derivatives: in vitro, in vivo and in silico studies for PTP-1B inhibition","volume":"87","author":"Ram\u00edrez-Espinosa","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117791_bib82","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1021\/acs.jnatprod.9b00262","article-title":"Prenylated phenolic compounds from the aerial parts of Glycyrrhiza Uralensis as PTP1B and \u03b1-Glucosidase inhibitors","volume":"83","author":"Fan","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2025.117791_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103706","article-title":"Identification of natural products as selective PTP1B inhibitors via virtual screening","volume":"98","author":"Yang","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"13","key":"10.1016\/j.ejmech.2025.117791_bib84","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1021\/acs.jafc.1c08089","article-title":"Six unusual meroterpenoids from the leaves of Psidium Guajava L. and their PTP1B inhibitory activities","volume":"70","author":"Xiao","year":"2022","journal-title":"J. Agric. Food Chem."},{"issue":"41","key":"10.1016\/j.ejmech.2025.117791_bib85","doi-asserted-by":"crossref","first-page":"11434","DOI":"10.1021\/acs.jafc.0c04615","article-title":"Nineteen new flavanol\u2013fatty alcohol hybrids with \u03b1-Glucosidase and PTP1B dual inhibition: one unusual type of antidiabetic constituent from amomum Tsao-Ko","volume":"68","author":"He","year":"2020","journal-title":"J. Agric. Food Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2025.117791_bib86","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1021\/acs.joc.1c00295","article-title":"Cajanusoids A\u2013D, unusual atropisomeric stilbene dimers with PTP1B inhibitory activities from the leaves of Cajanus Cajan","volume":"86","author":"He","year":"2021","journal-title":"J. Org. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2025.117791_bib87","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1021\/bi00174a040","article-title":"Protein tyrosine phosphatase substrate specificity: size and phosphotyrosine positioning requirements in peptide substrates","volume":"33","author":"Zhang","year":"1994","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117791_bib88","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/bbrc.1994.2435","article-title":"Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp","volume":"204","author":"Burke","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117791_bib89","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0968-0896(96)00195-2","article-title":"Potent inhibition of protein-tyrosine phosphatase by phosphotyrosine-mimic containing cyclic peptides","volume":"5","author":"Akamatsu","year":"1997","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2025.117791_bib90","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/cdd.2015.50","article-title":"The BCL-2 protein family, BH3-Mimetics and cancer therapy","volume":"22","author":"Delbridge","year":"2015","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117791_bib91","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bmcl.2018.11.047","article-title":"BH3 mimetics derived from Bim-BH3 domain core region show PTP1B inhibitory activity","volume":"29","author":"Lu","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"6","key":"10.1016\/j.ejmech.2025.117791_bib92","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1021\/acsmedchemlett.1c00174","article-title":"Discovery of novel PTP1B inhibitors derived from the BH3 domain of proapoptotic Bcl-2 proteins with antidiabetic potency","volume":"12","author":"Zhang","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117791_bib93","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1021\/acs.jmedchem.2c02003","article-title":"Discovery of novel PTP1B inhibitors with once-weekly therapeutic potential for type 2 diabetes: design, synthesis, and in vitro and in vivo investigations of BimBH3 peptide analogues","volume":"66","author":"Zhang","year":"2023","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2025.117791_bib94","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.bmcl.2012.02.070","article-title":"Discovery of novel and potent heterocyclic carboxylic acid derivatives as protein tyrosine phosphatase 1B inhibitors","volume":"22","author":"Basu","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"4","key":"10.1016\/j.ejmech.2025.117791_bib95","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.bmcl.2003.11.048","article-title":"The development of potent non-peptidic PTP-1B inhibitors","volume":"14","author":"Dufresne","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"248","key":"10.1016\/j.ejmech.2025.117791_bib96","first-page":"1","article-title":"The bacterial metabolite, lithocholic acid, has antineoplastic effects in pancreatic adenocarcinoma","volume":"10","author":"Schwarcz","year":"2024","journal-title":"Cell Death Discov."},{"issue":"23","key":"10.1016\/j.ejmech.2025.117791_bib97","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.1016\/j.bmcl.2012.09.040","article-title":"Synthesis and biological evaluation of 4,4-Dimethyl lithocholic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B","volume":"22","author":"He","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"30","key":"10.1016\/j.ejmech.2025.117791_bib98","first-page":"33224","article-title":"3-Benzylaminomethyl lithocholic acid derivatives exhibited potent and selective uncompetitive inhibitory activity against protein tyrosine phosphatase 1B (PTP1B)","volume":"9","author":"Mendoza-Jasso","year":"2024","journal-title":"ACS Omega"},{"issue":"129","key":"10.1016\/j.ejmech.2025.117791_bib99","doi-asserted-by":"crossref","first-page":"106551","DOI":"10.1039\/C5RA20238H","article-title":"Synthesis and biological evaluation of novel 2,3-Pyrazole Ring-Substituted-4,4-Dimethyl lithocholic acid derivatives as selective protein tyrosine phosphatase 1B (PTP1B) inhibitors with cellular efficacy","volume":"5","author":"Mao","year":"2015","journal-title":"RSC Adv."},{"issue":"14","key":"10.1016\/j.ejmech.2025.117791_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26144375","article-title":"Indole-and pyrazole-glycyrrhetinic acid derivatives as Ptp1b inhibitors: synthesis, in vitro and in silico studies","volume":"26","author":"De-La-cruz-mart\u00ednez","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117791_bib101","article-title":"Thiazolidinone: a structural motif of great synthetic and biological importance","volume":"1250","author":"Aqlan","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117791_bib102","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ejmech.2016.10.063","article-title":"Discovery of 4-[(5-Arylidene-4-Oxothiazolidin-3-Yl)Methyl]Benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: in silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agents","volume":"127","author":"Ottan\u00e0","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117791_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104483","article-title":"5-Aryl-Furan derivatives bearing a Phenylalanine- or isoleucine-derived rhodanine moiety as potential PTP1B inhibitors","volume":"106","author":"Niu","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117791_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2017.01.007","article-title":"Synthesis, biological evaluation and in silico studies of 5-(3-Methoxybenzylidene)Thiazolidine-2,4-Dione analogues as PTP1B inhibitors","volume":"71","author":"Mahapatra","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117791_bib105","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.biopha.2018.08.124","article-title":"Synthesis and evaluation of Thiazolidine-2,4-Dione\/Benzazole derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B): antihyperglycemic activity with molecular docking study","volume":"107","author":"Hidalgo-Figueroa","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117791_bib106","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.bmcl.2019.03.023","article-title":"Discovery of 1,3-Diphenyl-1H-Pyrazole derivatives containing Rhodanine-3-Alkanoic acid groups as potential PTP1B inhibitors","volume":"29","author":"Sun","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117791_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104648","article-title":"Discovery of 5-(3-Bromo-2-(2,3-Dibromo-4,5-Dimethoxybenzyl)-4,5-Dimethoxybenzylidene)Thiazolidine-2,4-Dione as a novel potent protein tyrosine phosphatase 1B inhibitor with antidiabetic properties","volume":"108","author":"Jiang","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117791_bib108","doi-asserted-by":"crossref","first-page":"8406","DOI":"10.1021\/acs.jmedchem.4c00676","article-title":"Identification of 1,3,4-Thiadiazolyl-Containing Thiazolidine-2,4-Dione derivatives as novel PTP1B inhibitors with antidiabetic activity","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117791_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106985","article-title":"New chromone derivatives bearing Thiazolidine-2,4-Dione moiety as potent PTP1B inhibitors: synthesis and biological activity evaluation","volume":"143","author":"Zheng","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117791_bib110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejmech.2012.09.015","article-title":"Design, synthesis, and evaluation of 2-Substituted ethenesulfonic acid ester derivatives as protein tyrosine phosphatase 1B inhibitors","volume":"57","author":"Liu","year":"2012","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117791_bib111","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.bmcl.2017.03.060","article-title":"Y-Shaped bis-arylethenesulfonic acid esters: potential potent and membrane permeable protein tyrosine phosphatase 1B inhibitors","volume":"27","author":"Yang","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117791_bib112","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ejmech.2018.12.032","article-title":"Investigation of stereoisomeric bisarylethenesulfonic acid esters for discovering potent and selective PTP1B inhibitors","volume":"164","author":"Xie","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117791_bib113","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2174\/1570193X19666220105145504","article-title":"Recent advances in the chemistry and biological activity of sulfonamide derivatives","volume":"19","author":"Yousif","year":"2022","journal-title":"Mini-Reviews Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117791_bib114","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bioorg.2019.01.052","article-title":"Toward a treatment of diabesity: rational design, synthesis and biological evaluation of benzene-sulfonamide derivatives as a new class of PTP-1B inhibitors","volume":"86","author":"Ghareb","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117791_bib115","article-title":"Biological evaluation, and molecular modelling of some benzene-sulfonamide derivatives as protein tyrosine Phosphatase-1B inhibitors for managing diabetes mellitus and associated metabolic disorders","author":"Ghareb","year":"2024","journal-title":"RSC Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2025.117791_bib116","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202400637","article-title":"Significance of triazole in medicinal chemistry: advancement in drug design, reward and biological activity","volume":"21","author":"Ajmal","year":"2024","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2025.117791_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116870","article-title":"A multi-potent motif in drug design","volume":"279","author":"Yuan","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117791_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103221","article-title":"Design, synthesis and biological evaluation of some Tetrazole acetamide derivatives as novel non-carboxylic PTP1B inhibitors","volume":"92","author":"Maheshwari","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117791_bib119","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bioorg.2018.06.008","article-title":"Design, synthesis of novel azolyl flavonoids and their protein tyrosine Phosphatase-1B inhibitory activities","volume":"80","author":"Zhang","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117791_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117240","article-title":"Isosteviol derivatives as protein tyrosine Phosphatase-1B inhibitors: synthesis, biological evaluation and molecular docking","volume":"83","author":"Li","year":"2023","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117791_bib121","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3390\/molecules24040678","article-title":"Bioactivity profile of the diterpene isosteviol and its derivatives","volume":"24","author":"Ullah","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117791_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103273","article-title":"Discovery of 2-Ethoxy-4-(Methoxymethyl)Benzamide derivatives as potent and selective PTP1B inhibitors","volume":"92","author":"Xie","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"18","key":"10.1016\/j.ejmech.2025.117791_bib123","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1002\/cmdc.202100338","article-title":"A computer-driven scaffold-hopping approach generating new PTP1B inhibitors from the Pyrrolo[1,2-a]Quinoxaline core","volume":"16","author":"Garc\u00eda-Mar\u00edn","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117791_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2022.100372","article-title":"Dithiocarbamates as potential PTP1B inhibitors for diabetes management","volume":"4","author":"Deshpande","year":"2022","journal-title":"Results Chem."},{"issue":"16","key":"10.1016\/j.ejmech.2025.117791_bib125","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1016\/j.bmcl.2019.06.011","article-title":"Identification and characterization of potent and selective inhibitors targeting protein tyrosine phosphatase 1B (PTP1B)","volume":"29","author":"Jin","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117791_bib126","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ejmech.2013.10.030","article-title":"Design, synthesis and molecular modelling studies of novel 3-Acetamido-4-Methyl benzoic acid derivatives as inhibitors of protein tyrosine phosphatase 1B","volume":"70","author":"Rakse","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117791_bib127","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.bmcl.2016.11.055","article-title":"Discovery of core-structurally novel PTP1B inhibitors with specific selectivity containing oxindole-fused spirotetrahydrofurochroman by one-pot reaction","volume":"27","author":"Dong","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117791_bib128","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejmech.2016.04.014","article-title":"Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity","volume":"118","author":"Liu","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"15","key":"10.1016\/j.ejmech.2025.117791_bib129","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1016\/j.bmc.2015.05.032","article-title":"Discovery of Novel, Potent, Selective and Cellular Active ADC Type PTP1B Inhibitors via Fragment-Docking-Oriented de Novel Design","volume":"23","author":"Du","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117791_bib130","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ejmech.2017.05.007","article-title":"Design, synthesis and biological evaluation of uncharged catechol derivatives as selective inhibitors of PTP1B","volume":"136","author":"Li","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117791_bib131","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bioorg.2019.03.053","article-title":"Dual targeting of PTP1B and glucosidases with new bifunctional iminosugar inhibitors to address type 2 diabetes","volume":"87","author":"Ferhati","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117791_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116938","article-title":"Design, synthesis and enzymatic inhibition evaluation of novel 4-Hydroxy Pd\u2013C-\u2162 derivatives as \u03b1-Glucosidase and PTP1B dual-target inhibitors","volume":"280","author":"Yang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117791_bib133","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/cbdd.14198","article-title":"Discovery and evaluation of biphenyl derivatives of 2-Iminobenzimidazoles as prototype dual PTP1B inhibitors and AMPK activators with in vivo antidiabetic activity","volume":"101","author":"Babkov","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2025.117791_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117545","article-title":"Discovery and biological evaluation of novel dual PTP1B and ACP1 inhibitors for the treatment of insulin resistance","volume":"97","author":"Feng","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117791_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104683","article-title":"Diarylheptanoid-Chalcone hybrids with PTP1B and \u03b1-Glucosidase dual inhibition from Alpinia Katsumadai","volume":"108","author":"He","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117791_bib136","article-title":"Synthesis and inhibitory activity of euparin derivatives as potential dual inhibitors against \u03b1-Glucosidase and protein tyrosine phosphatase 1B (PTP1B)","volume":"169","author":"Wang","year":"2023","journal-title":"Fitoterapia (Milano, 1934)"},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2025.117791_bib137","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drudis.2006.11.008","article-title":"Multi-target therapeutics: when the whole is greater than the sum of the parts","volume":"12","author":"Zimmermann","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2025.117791_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103927","article-title":"The antidiabetic drug lobeglitazone has the potential to inhibit PTP1B activity","volume":"100","author":"Rocha","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117791_bib139","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cbpa.2009.03.021","article-title":"The therapeutic potential of phosphatase inhibitors","volume":"13","author":"Vintonyak","year":"2009","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117791_bib140","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1021\/acsptsci.4c00054","article-title":"Site-specifically modified peptide inhibitors of protein tyrosine phosphatase 1B and T-Cell protein tyrosine phosphatase with enhanced stability and improved in vivo long-acting activity","volume":"7","author":"Zhang","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425005562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425005562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:08:09Z","timestamp":1762265289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425005562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":140,"alternative-id":["S0223523425005562"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117791","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into PTP1B inhibitors as antidiabetic agents: Current research and future perspectives","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117791","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117791"}}